HomeCompareBMXXY vs EQR

BMXXY vs EQR: Dividend Comparison 2026

BMXXY yields 0.79% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMXXY wins by $2.12M in total portfolio value· pulled ahead in Year 6
10 years
BMXXY
BMXXY
● Live price
0.79%
Share price
$12.44
Annual div
$0.10
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.16M
Annual income
$1,739,853.91
Full BMXXY calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — BMXXY vs EQR

📍 BMXXY pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMXXYEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMXXY + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BMXXY pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMXXY
Annual income on $10K today (after 15% tax)
$67.12/yr
After 10yr DRIP, annual income (after tax)
$1,478,875.82/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, BMXXY beats the other by $1,474,221.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMXXY + EQR for your $10,000?

BMXXY: 50%EQR: 50%
100% EQR50/50100% BMXXY
Portfolio after 10yr
$1.11M
Annual income
$872,664.75/yr
Blended yield
78.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

BMXXY
No analyst data
Altman Z
7.5
Piotroski
7/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMXXY buys
0
EQR buys
0
No recent congressional trades found for BMXXY or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMXXYEQR
Forward yield0.79%5.87%
Annual dividend / share$0.10$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%15.8%
Portfolio after 10y$2.16M$47.8K
Annual income after 10y$1,739,853.91$5,475.61
Total dividends collected$2.11M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BMXXY vs EQR ($10,000, DRIP)

YearBMXXY PortfolioBMXXY Income/yrEQR PortfolioEQR Income/yrGap
1$10,858$157.93$11,380$679.82$522.00EQR
2$11,938$320.51$13,014$837.25$1.1KEQR
3$13,433$658.71$14,961$1,036.20$1.5KEQR
4$15,759$1,385.36$17,297$1,289.22$1.5KEQR
5$19,899$3,037.77$20,121$1,613.15$222.00EQR
6← crossover$28,462$7,170.10$23,561$2,030.84+$4.9KBMXXY
7$49,624$19,169.19$27,783$2,573.54+$21.8KBMXXY
8$115,567$62,469.69$33,013$3,284.39+$82.6KBMXXY
9$395,588$271,931.01$39,547$4,223.51+$356.0KBMXXY
10$2,163,133$1,739,853.91$47,791$5,475.61+$2.12MBMXXY

BMXXY vs EQR: Complete Analysis 2026

BMXXYStock

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Full BMXXY Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this BMXXY vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMXXY vs SCHDBMXXY vs JEPIBMXXY vs OBMXXY vs KOBMXXY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.